Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

Launched by HAII CORP.LTD · Sep 25, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new tool called ALZGUARD, which is a smartphone app designed to help doctors diagnose dementia and other major cognitive disorders. The main goal is to see how well this app works compared to traditional methods used by healthcare professionals. Researchers also want to ensure that using the app is safe for patients.

To participate in the trial, you need to be between 55 and 85 years old and able to understand what the study is about. However, if you have trouble reading or using a smartphone, or if you have certain mental health conditions, you might not be eligible to take part. If you join the study, you’ll use the app and provide feedback on your experience. It's a great opportunity to help improve tools for diagnosing dementia while also receiving support!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be between 55 and 85 years old (both men and women).
• • Participants must be able to understand and voluntarily agree to the purpose, content, and procedures of the clinical trial.
• Exclusion Criteria:
• • Participants with no literacy or illiteracy.
• • Participants with an intellectual disability.
• • Participants with presenting active psychiatric symptoms.
• • Participants who have difficulty ALZGUARD application
• • Participants who are unable to use a smartphone, unless they can use it with assistant.
• • Participants with a history of suicidal ideation or suicidal complusion in the last 6 months.
• • Other conditions as deemed inappropriate for study participant by the Principal Investigator(PI).